Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calyxia has developed a patented microencapsulation technology enabling the production of high-performance, eco-engineered microcapsules and microspheres. These products are used by manufacturers in agriculture, consumer care, and advanced materials to improve product performance while meeting sustainability goals. The company’s NaturaCaps™ line enables precision agriculture with fully biodegradable capsules that reduce agrochemical usage and increase crop yields. Other lines target home/personal care products with microplastic-free solutions. The company has received significant investment to scale up production capacity. No clinical results as the company does not conduct drug trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calyxia.